Acurx Pharmaceuticals annual operating expenses
2020
2021
2022
2023
2024
2025
Acurx Pharmaceuticals Operating Expenses Growth & History (ACXP)
Acurx Pharmaceuticals's operating expenses was $8.1M for fiscal 2025.
View full Acurx Pharmaceuticals company overviewAcurx Pharmaceuticals annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.1M | −$6.0M | −42.70% |
| 2024 | 2024-12-31 | $14.1M | −$454,541 | −3.12% |
| 2023 | 2023-12-31 | $14.6M | $2.5M | +20.55% |
| 2022 | 2022-12-31 | $12.1M | −$721,424 | −5.63% |
| 2021 | 2021-12-31 | $12.8M | $8.2M | +178.57% |
| 2020 | 2020-12-31 | $4.6M | — | — |
Acurx Pharmaceuticals quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.3M | $37,545 | +1.65% |
| Q1 2026 | 2026-03-31 | $1.7M | −$460,494 | −21.16% |
| Q4 2025 | 2025-12-31 | $1.6M | −$1.2M | −42.17% |
| Q3 2025 | 2025-09-30 | $2.0M | −$797,897 | −28.23% |
| Q2 2025 | 2025-06-30 | $2.3M | −$1.9M | −44.95% |
| Q1 2025 | 2025-03-31 | $2.2M | −$2.2M | −50.28% |
| Q4 2024 | 2024-12-31 | $2.8M | −$2.3M | −45.33% |
| Q3 2024 | 2024-09-30 | $2.8M | −$288,383 | −9.26% |
| Q2 2024 | 2024-06-30 | $4.1M | $677,368 | +19.66% |
| Q1 2024 | 2024-03-31 | $4.4M | $1.5M | +50.81% |
| Q4 2023 | 2023-12-31 | $5.1M | $1.9M | +56.86% |
| Q3 2023 | 2023-09-30 | $3.1M | −$426,613 | −12.05% |
| Q2 2023 | 2023-06-30 | $3.4M | $824,707 | +31.47% |
| Q1 2023 | 2023-03-31 | $2.9M | $232,819 | +8.72% |
| Q4 2022 | 2022-12-31 | $3.3M | $633,424 | +24.11% |
| Q3 2022 | 2022-09-30 | $3.5M | −$1.1M | −23.71% |
| Q2 2022 | 2022-06-30 | $2.6M | −$1.5M | −35.62% |
| Q1 2022 | 2022-03-31 | $2.7M | $1.2M | +81.11% |
| Q4 2021 | 2021-12-31 | $2.6M | — | — |
| Q3 2021 | 2021-09-30 | $4.6M | $3.3M | +253.14% |
| Q2 2021 | 2021-06-30 | $4.1M | $3.2M | +345.67% |
| Q1 2021 | 2021-03-31 | $1.5M | — | — |
| Q3 2020 | 2020-09-30 | $1.3M | — | — |
| Q2 2020 | 2020-06-30 | $913,360 | — | — |
Acurx Pharmaceuticals operating expenses trends
Over the last five fiscal years, Acurx Pharmaceuticals's operating expenses increased from $4.6M to $8.1M, a change of $3.5M. The latest reported quarter, Q2 2026, shows $2.3M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acurx Pharmaceuticals source filings ↗